UCLA Hematologic Malignancy Program — Los Angeles, California

UCLA Hematologic Malignancy Program is a clinical research site located in Los Angeles, California, United States 90024.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA Hematologic Malignancy Program has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C).

Sponsors: Sun Pharma Advanced Research Company Limited.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematologic Malignancy Program?

UCLA Hematologic Malignancy Program has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematologic Malignancy Program conducted?

UCLA Hematologic Malignancy Program has 1 clinical trials on record, with 1 currently active. Their work covers Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C).

Is UCLA Hematologic Malignancy Program accredited by Crixeo Health?

UCLA Hematologic Malignancy Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematologic Malignancy Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.